Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines

Cheng,Tao; Wang,Xiao-Fei; Hou,Yun-Tian; Zhang,Li

doi:10.3892/mmr.2012.934

Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines

Authors:
- Tao Cheng
- Xiao-Fei Wang
- Yun-Tian Hou
- Li Zhang
View Affiliations

Affiliations: Beijing Institute of Transfusion Medicine, Beijing 100850, P.R. China, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China, 301st Hospital of Beijing, Beijing 100850, P.R. China, Shandong University, Jinan 250012, P.R. China
Published online on: June 6, 2012 https://doi.org/10.3892/mmr.2012.934
Pages: 581-584

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atrial fibrillation (AF) may occur and persist due to atrial remodeling exacerbated by inflammation. However, whether inflammatory cytokines, such as serum amyloid protein A (SAA), are elevated in patients with atrial arrhythmias remains unclear. In a case-control study design, serum levels of inflammatory cytokines SAA, IL-1, IL-6, TNF-α and high-sensitivity C-reactive protein (hsCRP) were compared between 122 patients with AF and 63 non-AF controls. Of 122 AF patients, 48 had lone AF and 74 organic AF; 65 had paroxysmal AF, 36 persistent AF and 21 permanent AF. In unadjusted analyses, the levels of SAA, hsCRP, TNF-αP, IL-1 and IL-6 were significantly higher in AF patients compared to control patients (P<0.01). Patients with permanent and persistent AF had higher serum levels of inflammatory cytokines than those with paroxysmal AF; all AF patients had higher serum levels than controls (P<0.05). Using a multivariate logistic regression analysis, we found that SAA (OR 3.11; 95% CI, 1.12-6.05), hsCRP (OR 2.53; 95% CI, 1.17-4.38), TNF-α (OR 1.80; 95% CI, 1.03-3.20) and IL-6 (OR 1.21; 95% CI, 0.68-2.87) were correlated with AF (P<0.05). SAA and related inflammatory cytokines are elevated in AF patients. This study is the first to document elevated SAA in AF patients. Although the cause of elevated SAA levels in AF patients remains unknown, elevated SAA may reflect an inflammatory state that promotes the occurrence and persistence of AF.

View Figures

View References

1	Go AS, Hylek EM, Phillips KA, et al: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 285:2370–2375. 2001. View Article : Google Scholar : PubMed/NCBI
2	Aviles RJ, Martin DO, Apperson-Hansen C, et al: Inflammation as a risk factor for atrial fibrillation. Circulation. 108:3006–3010. 2003. View Article : Google Scholar : PubMed/NCBI
3	Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA and Maseri A: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 96:1180–1184. 1997. View Article : Google Scholar : PubMed/NCBI
4	Bruins P, te Velthuis H, Yazdanbakhsh AP, et al: Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 96:3542–3548. 1997. View Article : Google Scholar
5	Kumagai K, Nakashima H and Saku K: The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res. 62:105–111. 2004. View Article : Google Scholar
6	Dernellis J and Panaretou M: Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J. 25:1100–1107. 2004. View Article : Google Scholar
7	Li D, Shinagawa K, Pang L, et al: Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation. 104:2608–2614. 2001. View Article : Google Scholar
8	Psychari SN, Apostolou TS, Sinos L, et al: Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 95:764–767. 2005. View Article : Google Scholar : PubMed/NCBI
9	Gabay C and Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340:448–454. 1999. View Article : Google Scholar : PubMed/NCBI
10	Urieli-Shoval S, Linke RP and Matzner Y: Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 7:64–69. 2000. View Article : Google Scholar : PubMed/NCBI
11	Yang RZ, Lee MJ, Hu H, et al: Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med. 3:2872006. View Article : Google Scholar : PubMed/NCBI
12	King VL, Thompson J and Tannock LR: Serum amyloid A in atherosclerosis. Curr Opin Lipidol. 22:302–307. 2011. View Article : Google Scholar : PubMed/NCBI
13	Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS and Kuchel GA: ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci. 63:879–884. 2008. View Article : Google Scholar : PubMed/NCBI
14	Steiner I and Hajkova P: Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy. Cardiovasc Pathol. 15:287–290. 2006. View Article : Google Scholar : PubMed/NCBI
15	Chung MK, Martin DO, Spricher D, et al: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 104:2886–2891. 2001. View Article : Google Scholar : PubMed/NCBI
16	Tannock LR, O’Brien KD, Knopp RH, et al: Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation. 111:3058–3062. 2005. View Article : Google Scholar : PubMed/NCBI
17	Sze L, Schmid C, Bloch KE, Bernays R and Brändle M: Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol. 156:321–329. 2007. View Article : Google Scholar : PubMed/NCBI
18	Xu H, Barnes GT, Yang Q, et al: Chronic inflammation in fat plays a crucial role in the development of obesity related insulin resistance. J Clin Invest. 112:1821–1830. 2003. View Article : Google Scholar : PubMed/NCBI